Concepedia

Ulrich Beyer

UB

33

Publications

2.4K

Citations

27

H-Index

1992

Active since

Affiliations

Roche (Switzerland)(Current)

Fondazione Salvatore Maugeri

Alessandro Manzoni Hospital

University Medical Center Freiburg

Marqués de Valdecilla University Hospital

Ulrich Beyer is an author at Roche (Switzerland) specializing in medicine, pharmacology, and chronic kidney disease.

ORCID

Top concepts

Publications per year

1992–2021

33

Publications

33

Immune-Modified Response Evaluation Criteria In Solid Tumors (imRECIST): Refining Guidelines to Assess the Clinical Benefit of Cancer Immunotherapy

F. Stephen Hodi, Marcus Ballinger, Benjamin Lyons et al. · Journal of Clinical Oncology · 2018 · 361 citations

Intravenous methoxy polyethylene glycol-epoetin beta for haemoglobin control in patients with chronic kidney disease who are on dialysis: a randomised non-inferiority trial (MAXIMA)

Nathan W. Levin, Steven Fishbane, Francisco Valdés Cañedo et al. · The Lancet · 2007 · 157 citations

, , +8

Transferrin Conjugates of Doxorubicin: Synthesis, Characterization, Cellular Uptake, and in Vitro Efficacy||

Felix Kratz, Ulrich Beyer, Thomas Roth et al. · Journal of Pharmaceutical Sciences · 1998 · 152 citations

Once-Monthly Subcutaneous C.E.R.A. Maintains Stable Hemoglobin Control in Patients with Chronic Kidney Disease on Dialysis and Converted Directly from Epoetin One to Three Times Weekly

Francesco Locatelli, Jean‐Philippe Ryckelynck, József Balla et al. · Clinical Journal of the American Society of Nephrology · 2007 · 137 citations

Prolongation of hospital stay and extra costs due to ventilator-associated pneumonia in an intensive care unit

I. Kappstein, Gabi Schulgen, Ulrich Beyer et al. · European Journal of Clinical Microbiology & Infectious Diseases · 1992 · 133 citations · Full text

, , +7

Rows per page

1–5 of 33